• Lundbeck raised its 2026 revenue growth forecast to 11%-12% at constant exchange rates from 7%-9% on November 10.
• Adjusted EBITDA growth guidance increased to 15%-19% at constant exchange rates from 8%-14%.
• Stronger Vyepti sales and mature-brand growth supported the upgrade; lower gross margins partly offset higher gross profit.
• Nine-month revenue rose 13% at constant exchange rates to DKK 20.19 billion, with Vyepti sales growing 45%.
• Full-year adjusted gross margin is forecast at 86%-87%; research and development costs are expected at DKK 5.6 billion-DKK 5.7 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. H. Lundbeck A/S published the original content used to generate this news brief on November 11, 2026, and is solely responsible for the information contained therein.